dr. rugo on the efficacy of bevacizumab in breast cancer
Published 12 years ago • 174 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
0:59
dr. rugo on vegf-a as an avastin response predictor
-
1:39
dr. rugo on anti-angiogenesis therapy response predictors
-
1:19
real-world use of bevacizumab in patients with breast cancer
-
1:55
dr. rugo on pathway blockade in breast cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
1:57
dr. rugo on results of oral paclitaxel with encequidar in metastatic breast cancer
-
22:26
what's your approach? treating myelofibrosis
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
1:42
dr. rugo on chemotherapy for metastatic breast cancer
-
1:06
dr. rugo on guidelines for the treatment of metastatic breast cancer
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
4:12
assessing the use of bevacizumab
-
0:59
dr. rugo on pi3k and mtor inhibitors for the treatment of breast cancer
-
1:11
dr. rugo on the significance of the monarch i trial for breast cancer
-
0:59
dr. hope rugo on safety of trastuzumab biosimilar for her2 breast cancer
-
2:07
dr. rugo on the advances in the treatment of her2-positive breast cancer
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer